Open-mkt buys · 90d
$268.0K
10 trades · 5 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$268.0K
Insiders on file
20
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | 8 | $20.0K | $0 | 2026-08-07 |
| Canning John Charles | Chief Operating Officer | 7 | $28.0K | $0 | 2026-08-07 |
| Sipos Jeremy Alexander | Chief Technology Officer | 7 | $20.0K | $0 | 2026-08-07 |
| Lee-Sepsick Kathy | Chief Executive Officer, Director | 22 | $100.0K | $0 | 2026-08-07 |
| Elefant Dov | Chief Financial Officer | 22 | $100.0K | $0 | 2026-08-07 |
| Eichenbaum Kenneth D. | Director | 4 | $0 | $0 | 2026-06-24 |
| Milnes Alistair | Director | 5 | $0 | $0 | 2026-06-24 |
| Larsen Charles | Director | 15 | $91.0K | $0 | 2026-06-24 |
| Uzialko Edward R | Director, 10% Owner | 11 | $1.30M | $0 | 2026-06-24 |
| Silverman Joshua | Director | 3 | $0 | $0 | 2025-06-25 |
| Nicholas Kelley Stinson | Chief Commercial Officer | 1 | $0 | $0 | 2025-06-23 |
| Currie Daniel Scott | Senior VP, Operations | 8 | $0 | $0 | 2025-06-02 |
| Thomas Christine E | SVP, Regulatory & Clinical | 6 | $0 | $0 | 2025-01-28 |
| Spector Richard D. | Chief Commercial Officer | 1 | $0 | $0 | 2024-02-12 |
| Morrissey Anne | Director | 2 | $0 | $0 | 2023-06-21 |
| Perrow Wendy | Director | 3 | $0 | $0 | 2023-06-21 |
| Kendall Keith J | Director | 1 | $0 | $0 | 2023-06-14 |
| Adams John Q JR | Director | 6 | $520.0K | $0 | 2022-06-08 |
| Dyett John | Director, 10% Owner | 13 | $691.7K | $0 | 2022-06-08 |
| Witte William Benson | Director | 1 | $0 | $0 | 2021-12-15 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 15,625 | — | $0 | 15,625 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 15,625 | — | $0 | 15,625 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 15,625 | — | $0 | 15,625 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 15,625 | — | $0 | 15,625 | SEC↗ |
| Canning John Charles | Chief Operating Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 4,375 | — | $0 | 4,375 | SEC↗ |
| Canning John Charles | Chief Operating Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 4,375 | — | $0 | 4,375 | SEC↗ |
| Sipos Jeremy Alexander | Chief Technology Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 3,125 | — | $0 | 3,125 | SEC↗ |
| Sipos Jeremy Alexander | Chief Technology Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 3,125 | — | $0 | 3,125 | SEC↗ |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affai | A Award deriv | 2026-08-07 | 2026-08-11 | 3,125 | — | $0 | 3,125 | SEC↗ |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affai | A Award deriv | 2026-08-07 | 2026-08-11 | 3,125 | — | $0 | 3,125 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | P Buy | 2026-08-07 | 2026-08-11 | 15,625 | $3.20 | $50.0K | 15,625 | SEC↗ |
| Elefant Dov | Chief Financial Officer | P Buy | 2026-08-07 | 2026-08-11 | 15,625 | $3.20 | $50.0K | 15,625 | SEC↗ |
| Canning John Charles | Chief Operating Officer | P Buy | 2026-08-07 | 2026-08-11 | 4,375 | $3.20 | $14.0K | 4,375 | SEC↗ |
| Sipos Jeremy Alexander | Chief Technology Officer | P Buy | 2026-08-07 | 2026-08-11 | 3,125 | $3.20 | $10.0K | 3,125 | SEC↗ |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affai | P Buy | 2026-08-07 | 2026-08-11 | 3,125 | $3.20 | $10.0K | 3,125 | SEC↗ |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affai | A Award deriv | 2026-08-07 | 2026-08-11 | 3,125 | — | — | 3,125 | SEC↗ |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affai | A Award deriv | 2026-08-07 | 2026-08-11 | 3,125 | — | — | 3,125 | SEC↗ |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affai | P Buy | 2026-08-07 | 2026-08-11 | 3,125 | $3.20 | $10.0K | 3,125 | SEC↗ |
| Sipos Jeremy Alexander | Chief Technology Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 3,125 | — | — | 3,125 | SEC↗ |
| Sipos Jeremy Alexander | Chief Technology Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 3,125 | — | — | 3,125 | SEC↗ |
| Sipos Jeremy Alexander | Chief Technology Officer | P Buy | 2026-08-07 | 2026-08-11 | 3,125 | $3.20 | $10.0K | 3,125 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer, Dir | A Award deriv | 2026-08-07 | 2026-08-11 | 15,625 | — | — | 15,625 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer, Dir | A Award deriv | 2026-08-07 | 2026-08-11 | 15,625 | — | — | 15,625 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer, Dir | P Buy | 2026-08-07 | 2026-08-11 | 15,625 | $3.20 | $50.0K | 15,625 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 15,625 | — | — | 15,625 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 15,625 | — | — | 15,625 | SEC↗ |
| Elefant Dov | Chief Financial Officer | P Buy | 2026-08-07 | 2026-08-11 | 15,625 | $3.20 | $50.0K | 15,625 | SEC↗ |
| Canning John Charles | Chief Operating Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 4,375 | — | — | 4,375 | SEC↗ |
| Canning John Charles | Chief Operating Officer | A Award deriv | 2026-08-07 | 2026-08-11 | 4,375 | — | — | 4,375 | SEC↗ |
| Canning John Charles | Chief Operating Officer | P Buy | 2026-08-07 | 2026-08-11 | 4,375 | $3.20 | $14.0K | 4,375 | SEC↗ |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affai | A Award deriv | 2026-07-06 | 2026-08-11 | 6,250 | — | $0 | 6,250 | SEC↗ |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affai | A Award deriv | 2026-07-06 | 2026-08-11 | 6,250 | — | $0 | 6,250 | SEC↗ |
| Larsen Charles | Director | A Award deriv | 2026-06-24 | 2026-08-11 | 880 | — | $0 | 880 | SEC↗ |
| Milnes Alistair | Director | A Award deriv | 2026-06-24 | 2026-08-11 | 880 | — | $0 | 880 | SEC↗ |
| Uzialko Edward R | Director | A Award deriv | 2026-06-24 | 2026-08-11 | 880 | — | $0 | 880 | SEC↗ |
| Eichenbaum Kenneth D. | Director | A Award deriv | 2026-06-24 | 2026-08-11 | 880 | — | $0 | 880 | SEC↗ |
| Uzialko Edward R | Director | A Award deriv | 2026-06-24 | 2026-08-11 | 880 | — | $0 | 880 | SEC↗ |
| Milnes Alistair | Director | A Award deriv | 2026-06-24 | 2026-08-11 | 880 | — | $0 | 880 | SEC↗ |
| Larsen Charles | Director | A Award deriv | 2026-06-24 | 2026-08-11 | 880 | — | $0 | 880 | SEC↗ |
| Eichenbaum Kenneth D. | Director | A Award deriv | 2026-06-24 | 2026-08-11 | 880 | — | $0 | 880 | SEC↗ |
| Canning John Charles | Chief Operating Officer | A Award deriv | 2026-03-30 | 2026-04-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Larsen Charles | Director | A Award deriv | 2026-03-19 | 2026-03-27 | 34,122 | — | $0 | 34,122 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2026-03-19 | 2026-03-27 | 68,244 | — | $0 | 68,244 | SEC↗ |
| Eichenbaum Kenneth D. | Director | A Award deriv | 2026-03-19 | 2026-03-27 | 102,366 | — | $0 | 102,366 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2026-03-19 | 2026-03-27 | 34,122 | — | $0 | 34,122 | SEC↗ |
| Eichenbaum Kenneth D. | Director | A Award deriv | 2026-03-18 | 2026-03-20 | 35,200 | — | $0 | 35,200 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2026-02-19 | 2026-02-20 | 173,000 | — | $0 | 173,000 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2026-02-19 | 2026-02-20 | 169,000 | — | $0 | 169,000 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2026-02-19 | 2026-02-20 | 447,000 | — | $0 | 447,000 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2026-02-19 | 2026-02-20 | 282,000 | — | $0 | 282,000 | SEC↗ |
| Sipos Jeremy Alexander | Chief Technology Officer | A Award deriv | 2026-02-02 | 2026-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Elefant Dov | Chief Financial Officer | I Discretionary deriv | 2025-11-07 | 2025-11-12 | 0 | — | $0 | 0 | SEC↗ |
| Elefant Dov | Chief Financial Officer | I Discretionary deriv | 2025-11-07 | 2025-11-12 | 34,122 | — | $0 | 34,122 | SEC↗ |
| Elefant Dov | Chief Financial Officer | I Discretionary deriv | 2025-11-07 | 2025-11-12 | 34,122 | — | $0 | 34,122 | SEC↗ |
| Elefant Dov | Chief Financial Officer | I Discretionary deriv | 2025-11-07 | 2025-11-12 | 34,122 | — | $0 | 34,122 | SEC↗ |
| Larsen Charles | Director | I Discretionary deriv | 2025-11-07 | 2025-11-12 | 0 | — | $0 | 0 | SEC↗ |
| Larsen Charles | Director | I Discretionary deriv | 2025-11-07 | 2025-11-12 | 34,122 | — | $0 | 34,122 | SEC↗ |
| Larsen Charles | Director | I Discretionary deriv | 2025-11-07 | 2025-11-12 | 34,122 | — | $0 | 34,122 | SEC↗ |
| Larsen Charles | Director | I Discretionary deriv | 2025-11-07 | 2025-11-12 | 34,122 | — | $0 | 34,122 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | I Discretionary deriv | 2025-11-07 | 2025-11-19 | 68,244 | — | $0 | 68,244 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | I Discretionary deriv | 2025-11-07 | 2025-11-19 | 68,244 | — | $0 | 68,244 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | I Discretionary deriv | 2025-11-07 | 2025-11-19 | 0 | — | $0 | 0 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | I Discretionary deriv | 2025-11-07 | 2025-11-19 | 68,244 | — | $0 | 68,244 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | I Discretionary deriv | 2025-08-27 | 2025-08-28 | 48,535 | — | $0 | 48,535 | SEC↗ |
| Elefant Dov | Chief Financial Officer | I Discretionary deriv | 2025-08-27 | 2025-08-28 | 38,828 | — | $0 | 38,828 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | I Discretionary | 2025-08-27 | 2025-08-28 | 48,535 | — | $0 | 360,627 | SEC↗ |
| Elefant Dov | Chief Financial Officer | I Discretionary | 2025-08-27 | 2025-08-28 | 38,828 | — | $0 | 58,436 | SEC↗ |
| Silverman Joshua | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Larsen Charles | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Milnes Alistair | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Uzialko Edward R | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Nicholas Kelley Stinson | Chief Commercial Officer | A Award deriv | 2025-06-23 | 2025-07-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | I Discretionary | 2025-06-02 | 2025-06-04 | 34,314 | $1.02 | $35.0K | 312,092 | SEC↗ |
| Elefant Dov | Chief Financial Officer | I Discretionary | 2025-06-02 | 2025-06-04 | 19,608 | $1.02 | $20.0K | 19,608 | SEC↗ |
| Currie Daniel Scott | Chief Operating Officer | I Discretionary | 2025-06-02 | 2025-06-04 | 19,608 | $1.02 | $20.0K | 86,275 | SEC↗ |
| Larsen Charles | Director | I Discretionary | 2025-06-02 | 2025-06-04 | 24,510 | $1.02 | $25.0K | 56 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2025-01-29 | 2025-01-30 | 262,700 | — | $0 | 262,700 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2025-01-29 | 2025-01-30 | 120,353 | — | $0 | 120,353 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2025-01-29 | 2025-01-30 | 59,849 | — | $0 | 59,849 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 72,045 | — | $0 | 72,045 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 114,300 | — | $0 | 114,300 | SEC↗ |
| Thomas Christine E | Chief Reg & Clinical Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 28,682 | — | $0 | 28,682 | SEC↗ |
| Thomas Christine E | Chief Reg & Clinical Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 55,090 | — | $0 | 55,090 | SEC↗ |
| Thomas Christine E | Chief Reg & Clinical Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 23,600 | — | $0 | 23,600 | SEC↗ |
| Currie Daniel Scott | Chief Operating Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 140,700 | — | $0 | 140,700 | SEC↗ |
| Currie Daniel Scott | Chief Operating Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 59,313 | — | $0 | 59,313 | SEC↗ |
| Currie Daniel Scott | Chief Operating Officer | A Award deriv | 2025-01-28 | 2025-01-30 | 29,184 | — | $0 | 29,184 | SEC↗ |
| Uzialko Edward R | Director | A Award deriv | 2024-07-12 | 2024-07-15 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Milnes Alistair | Director | A Award deriv | 2024-07-12 | 2024-07-15 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Larsen Charles | Director | A Award deriv | 2024-07-12 | 2024-07-15 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Silverman Joshua | Director | A Award deriv | 2024-07-12 | 2024-07-15 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Spector Richard D. | Chief Commercial Officer | A Award deriv | 2024-02-12 | 2024-02-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2024-02-01 | 2024-02-02 | 204,900 | — | $0 | 204,900 | SEC↗ |
| Thomas Christine E | SVP, Regulatory & Clinical | A Award deriv | 2024-02-01 | 2024-02-02 | 32,600 | — | $0 | 32,600 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2024-02-01 | 2024-02-02 | 84,000 | — | $0 | 84,000 | SEC↗ |
| Currie Daniel Scott | Chief Operating Officer | A Award deriv | 2024-02-01 | 2024-02-02 | 61,900 | — | $0 | 61,900 | SEC↗ |
| Silverman Joshua | Director | A Award deriv | 2023-11-21 | 2023-11-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Thomas Christine E | SVP, Regulatory & Clinical | A Award deriv | 2023-10-10 | 2023-11-01 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2023-07-03 | 2023-07-03 | 270,400 | — | $0 | 270,400 | SEC↗ |
| Lee-Sepsick Kathy | Chief Executive Officer | A Award deriv | 2023-07-03 | 2023-07-03 | 271,900 | — | $0 | 271,900 | SEC↗ |
| Currie Daniel Scott | Senior VP, Operations | A Award deriv | 2023-07-03 | 2023-07-03 | 84,600 | — | $0 | 84,600 | SEC↗ |
| Currie Daniel Scott | Senior VP, Operations | A Award deriv | 2023-07-03 | 2023-07-03 | 124,800 | — | $0 | 124,800 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2023-07-03 | 2023-07-03 | 204,700 | — | $0 | 204,700 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2023-07-03 | 2023-07-03 | 105,200 | — | $0 | 105,200 | SEC↗ |
| Uzialko Edward R | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Perrow Wendy | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Larsen Charles | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Morrissey Anne | Director | A Award deriv | 2023-06-21 | 2023-06-23 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Kendall Keith J | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Milnes Alistair | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Thomas Christine E | SVP, Regulatory & Clinical | A Award deriv | 2022-10-10 | 2022-10-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Uzialko Edward R | Director, 10% Owner | A Award deriv | 2022-06-08 | 2022-06-10 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Adams John Q JR | Director | A Award deriv | 2022-06-08 | 2022-06-10 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Larsen Charles | Director | A Award deriv | 2022-06-08 | 2022-06-10 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Morrissey Anne | Director | A Award deriv | 2022-06-08 | 2022-06-10 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Perrow Wendy | Director | A Award deriv | 2022-06-08 | 2022-06-10 | 8,500 | — | $0 | 25,500 | SEC↗ |
| Dyett John | Director | A Award deriv | 2022-06-08 | 2022-06-10 | 8,500 | — | $0 | 8,500 | SEC↗ |
| Elefant Dov | Chief Financial Officer | A Award deriv | 2022-02-28 | 2022-03-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Perrow Wendy | Director | A Award deriv | 2022-01-25 | 2022-01-27 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Currie Daniel Scott | Senior VP, Operations | A Award deriv | 2022-01-25 | 2022-01-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Witte William Benson | Director | J Other | 2021-12-15 | 2021-12-17 | 12,191 | — | $0 | 12,191 | SEC↗ |
| Dyett John | Director | J Other | 2021-12-15 | 2021-12-17 | 3,219,795 | — | $0 | 0 | SEC↗ |
| Dyett John | Director | J Other | 2021-12-15 | 2021-12-17 | 175,635 | — | $0 | 290,344 | SEC↗ |
| Dyett John | Director, 10% Owner | P Buy | 2021-06-23 | 2021-06-24 | 1,000 | $9.95 | $9.9K | 114,709 | SEC↗ |
| Dyett John | Director, 10% Owner | C Conversion deriv | 2021-06-22 | 2021-06-24 | 2,271,453 | — | $0 | 0 | SEC↗ |
| Dyett John | Director, 10% Owner | C Conversion deriv | 2021-06-22 | 2021-06-24 | 63,709 | — | $0 | 0 | SEC↗ |
| Dyett John | Director, 10% Owner | C Conversion deriv | 2021-06-22 | 2021-06-24 | 948,342 | — | $0 | 0 | SEC↗ |
| Adams John Q JR | Director | C Conversion deriv | 2021-06-22 | 2021-06-24 | 91,245 | — | $0 | 0 | SEC↗ |
| Adams John Q JR | Director | C Conversion deriv | 2021-06-22 | 2021-06-24 | 108,693 | — | $0 | 0 | SEC↗ |
| Larsen Charles | Director | C Conversion deriv | 2021-06-22 | 2021-06-24 | 10,587 | — | $0 | 0 | SEC↗ |
| Uzialko Edward R | Director | C Conversion deriv | 2021-06-22 | 2021-06-24 | 1,059,445 | — | $0 | 0 | SEC↗ |
| Uzialko Edward R | Director | C Conversion deriv | 2021-06-22 | 2021-06-24 | 30,175 | — | $0 | 0 | SEC↗ |
| Dyett John | Director, 10% Owner | C Conversion | 2021-06-22 | 2021-06-24 | 63,709 | — | $0 | 113,709 | SEC↗ |
| Dyett John | Director, 10% Owner | P Buy | 2021-06-22 | 2021-06-24 | 40,000 | $13.00 | $520.0K | 50,000 | SEC↗ |
| Dyett John | Director, 10% Owner | C Conversion | 2021-06-22 | 2021-06-24 | 2,271,453 | — | $0 | 3,219,795 | SEC↗ |
| Dyett John | Director, 10% Owner | C Conversion | 2021-06-22 | 2021-06-24 | 948,342 | — | $0 | 948,342 | SEC↗ |
| Adams John Q JR | Director | C Conversion | 2021-06-22 | 2021-06-24 | 91,245 | — | $0 | 131,245 | SEC↗ |
| Adams John Q JR | Director | C Conversion | 2021-06-22 | 2021-06-24 | 108,693 | — | $0 | 239,938 | SEC↗ |
| Adams John Q JR | Director | P Buy | 2021-06-22 | 2021-06-24 | 40,000 | $13.00 | $520.0K | 40,000 | SEC↗ |
| Larsen Charles | Director | C Conversion | 2021-06-22 | 2021-06-24 | 10,587 | — | $0 | 17,587 | SEC↗ |
| Larsen Charles | Director | P Buy | 2021-06-22 | 2021-06-24 | 7,000 | $13.00 | $91.0K | 7,000 | SEC↗ |
| Uzialko Edward R | Director | C Conversion | 2021-06-22 | 2021-06-24 | 1,059,445 | — | $0 | 1,187,231 | SEC↗ |
| Uzialko Edward R | Director | C Conversion | 2021-06-22 | 2021-06-24 | 30,175 | — | $0 | 30,175 | SEC↗ |
| Uzialko Edward R | Director | P Buy | 2021-06-22 | 2021-06-24 | 100,000 | $13.00 | $1.30M | 127,786 | SEC↗ |
| Dyett John | Director, 10% Owner | P Buy | 2021-06-18 | 2021-06-24 | 10,000 | $12.88 | $128.8K | 10,000 | SEC↗ |
| Dyett John | Director, 10% Owner | P Buy | 2021-06-18 | 2021-06-24 | 2,500 | $13.18 | $33.0K | 2,500 | SEC↗ |